Literature DB >> 11465111

Immunobiology of CD28 expression on human neutrophils. I. CD28 regulates neutrophil migration by modulating CXCR-1 expression.

K Venuprasad1, P Parab, D V Prasad, S Sharma, P R Banerjee, M Deshpande, D K Mitra, S Pal, R Bhadra, D Mitra, B Saha.   

Abstract

CD28, described as a T cell costimulatory molecule so far, is expressed on human peripheral blood neutrophils, as shown by cell surface staining and immunoprecipitation with anti-CD28 monoclonal antibody, and by reverse transcription PCR. The phorbol 12-myristate 13-acetate-augmented expression of CD28 on these cells can be blocked by actinomycin D, an RNA transcription inhibitor, and staurosporin, a protein kinase inhibitor. Cross-linking of CD28 results in an early increase in IL-8 receptor A (IL-8RA or CXCR-1) expression and a concurrent increase in IL-8-induced chemotaxis. The expression of CXCR-1 is down-regulated by receptor internalization 3 h after CD28 cross-linking with concurrent decrease in IL-8-induced chemotactic migration. Thus, our results demonstrate for the first time that CD28 is expressed on human peripheral blood neutrophils and that CD28 may play an important role in the regulation of IL-8RA expression and migration of neutrophils in response to IL-8.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465111     DOI: 10.1002/1521-4141(200105)31:5<1536::AID-IMMU1536>3.0.CO;2-8

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

2.  CTLA4-Ig inhibits allergic airway inflammation by a novel CD28-independent, nitric oxide synthase-dependent mechanism.

Authors:  Christine M Deppong; Amit Parulekar; Jonathan S Boomer; Traci L Bricker; Jonathan M Green
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

Review 3.  The pharmacology of second-generation chimeric antigen receptors.

Authors:  Sjoukje J C van der Stegen; Mohamad Hamieh; Michel Sadelain
Journal:  Nat Rev Drug Discov       Date:  2015-07       Impact factor: 84.694

4.  A variable immunoreceptor in a subpopulation of human neutrophils.

Authors:  Kerstin Puellmann; Wolfgang E Kaminski; Mandy Vogel; C Thomas Nebe; Josef Schroeder; Hans Wolf; Alexander W Beham
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

5.  Were monocytes responsible for initiating the cytokine storm in the TGN1412 clinical trial tragedy?

Authors:  G P Sandilands; M Wilson; C Huser; L Jolly; W A Sands; C McSharry
Journal:  Clin Exp Immunol       Date:  2010-10-21       Impact factor: 4.330

Review 6.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

7.  CD28 Deficiency Enhances Type I IFN Production by Murine Plasmacytoid Dendritic Cells.

Authors:  Monica Macal; Miguel A Tam; Charles Hesser; Jeremy Di Domizio; Psylvia Leger; Michel Gilliet; Elina I Zuniga
Journal:  J Immunol       Date:  2016-01-15       Impact factor: 5.422

Review 8.  CARs: Beyond T Cells and T Cell-Derived Signaling Domains.

Authors:  Nico M Sievers; Jan Dörrie; Niels Schaft
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

Review 9.  Targeting co-stimulatory molecules in autoimmune disease.

Authors:  Natalie M Edner; Gianluca Carlesso; James S Rush; Lucy S K Walker
Journal:  Nat Rev Drug Discov       Date:  2020-09-16       Impact factor: 112.288

Review 10.  The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy.

Authors:  James E Pease; Ian Sabroe
Journal:  Am J Respir Med       Date:  2002
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.